NEKTAR THERAPEUTICS — Director's Dealing 2020

Jul 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2020-07-09

Reporting Person: GREER R SCOTT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-09	Common Stock	M	40000	$9.24	Acquired	191583	Direct
2020-07-09	Common Stock	S	15009	$25.00	Disposed	176574	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-09	Stock Option	$9.24	M	40000	Disposed	2020-09-13	Common Stock (40000)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.